Ocean FX Spectrometer Provides High Acquisition Speed
Newest spectrometer from Ocean Optics offers Ethernet operation, speed, sensitivity and spectral buffering...
List view / Grid view
News
Price drops make more cancer drugs routinely available
7 March 2017 | By Steve Bremer, Managing Editor
The National Institute for Health and Care Excellence (NICE) is half way through a review of drugs approved and still available only through the old Cancer Drugs Fund (CDF). In all cases so far where NICE has been able to make recommendations for routine NHS use, companies have reviewed and…
Watson-Marlow launches new bioprocessing pump technology at INTERPHEX 2017
7 March 2017 | By Watson-Marlow
Watson-Marlow Fluid Technology Group (WMFTG) the world leader in peristaltic pumps and associated fluid path technologies, will be unveiling a host of products at INTERPHEX 2017 including a new bioprocessing pump. Visitors to booth 2833 will witness a step change in tangential flow filtration (TFF), virus filtration (VF) and high-performance…
UK life sciences sector productivity double national average
7 March 2017 | By Steve Bremer, Managing Editor
The PwC report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British In Vitro Diagnostics Association (BIVDA), shows that the average productivity of UK life sciences employees, expressed as gross value…
AbbVie receives CHMP positive opinion for Hep C tablet combination
2 March 2017 | By Niamh Marriott, Digital Editor
The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) + Exviera (dasabuvir tablets) as an option for previously untreated adult patients with geotype 1b chronic hepatitis C virus (HCV)…
NICE does not recommend Merck’s lung cancer drug
2 March 2017 | By Niamh Marriott, Digital Editor
NICE has published draft guidance which does not recommend Keytruda, also known as pembrolizumab, for untreated PD-L1-positive metastatic lung cancer...
Richmond unveils new clinical research centre in central London
1 March 2017 | By Niamh Marriott, Digital Editor
European Pharmaceutical Review was invited to the grand opening Richmond Pharmacology's new clinical research facility in central London.
Janssen’s monoclonal antibody receives positive CHMP opinion to treat multiple myeloma
28 February 2017 | By Niamh Marriott, Digital Editor
If approved by the European Commission, daratumumab can be used for the treatment of adult patients with multiple myeloma...
Novartis receives positive CHMP opinion for lung cancer combination
27 February 2017 | By Niamh Marriott, Digital Editor
The EMA approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with non-small cell lung cancer...
AstraZeneca Phase III breast cancer trial met primary endpoint
23 February 2017 | By Niamh Marriott, Digital Editor
AstraZeneca announced positive results from its Phase III trial comparing Lynparza to chemotherapy, to treat HER2-negative metastatic breast cancer...
First biosimilar mAb in oncology granted EU approval
23 February 2017 | By Niamh Marriott, Digital Editor
The European Commission has approved Truxima (biosimilar rituximab) for all indications of reference rituximab in the European Union.
Vibratory sifters assure product quality and heighten productivity for global pharmaceutical manufacturers
The use of industrial sieving equipment in pharmaceutical manufacturing is critical to ensure product quality and integrity. To keep up with growing product demand, most pharmaceutical manufacturers must also improve productivity while protecting the health and safety of operators.
Apitope’s Phase II multiple sclerosis trial a success
22 February 2017 | By Niamh Marriott, Digital Editor
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical study of its lead product candidate, ATX-MS-1467, for the treatment of patients with multiple sclerosis. The Phase IIa, open-label, one arm study evaluated the effects of…
New mid-infrared laser system could detect atmospheric chemicals
21 February 2017 | By Niamh Marriott, Digital Editor
Researchers at MIT have found a new way of using mid-infrared lasers to turn regions of molecules into glowing filaments of electrically charged gas...
Scientists developed a miniature gas sensor for mobile devices
21 February 2017 | By Niamh Marriott, Digital Editor
VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices.
